Investing.com - Bicycle Therapeutics (NASDAQ:BCYC) reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Bicycle Therapeutics announced earnings per share of $-0.74 on revenue of $1.79M. Analysts polled by Investing.com anticipated EPS of $-0.7111 on revenue of $2.31M.
Bicycle Therapeutics shares are up 63.84% from the beginning of the year, still down 20.49% from its 52 week high of $36.99 set on July 23. They are outperforming the Nasdaq which is up 14.68% from the start of the year.
Bicycle Therapeutics follows other major Healthcare sector earnings this month
Bicycle Therapeutics's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar